Protein kinase A is a target for aging and the aging heart

Aging

Volumn 2, Issue 4, 2010, Pages 238-243

  Enns, Linda C ^a   Pettan Brewer, Christina ^a   Ladiges, Warren ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AMPK; Beta adrenergic receptors; Enhanced cardiac function; Leptin signaling; Lifespan extension; Mouse models of aging; Obesity resistance

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIBETA;

AGING; ANIMAL; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; C57BL MOUSE; ENZYMOLOGY; FATTY LIVER; FEMALE; GENETICS; HEART; HEART DISEASE; HUMAN; MALE; MOUSE; MOUSE MUTANT; OBESITY; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIIBETA SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FATTY LIVER; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 78049489562     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100138     Document Type: Article

References (27)

1. Niswender CM, Ishihara RW, Judge LM, Zhang C, Shokat KM, McKnight GS. Protein engineering of protein kinase A catalytic subunits results in the acquisition of novel inhibitor sensitivity. J Biol Chem. 2002; 277: 28916-28922.
2. McKnight GS. Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain. Curr Opin Cell Biol. 1991;3:213-217.
3. Brandon EP, Idzerda RL, McKnight GS. PKA isoforms, neural pathways, and behaviour: making the connection. Curr Opin Neurobiol. 1997; 7:397-403.
4. Enns L, Morton J, Treuting P, Emond M, Wold N, McKnight GS, Rabinovitch P, Ladiges W. Disruption of protein kinase A in mice enhances healthy aging. PLoS. 2009; 4:e5963.
5. Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, Maccoss MJ, Gollahon K, Martin GM, Loeb LA, Ladiges WC, Rabinovitch PS. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation. 2009; 119:2789-2797.
6. Lakatta EG and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107:346-354.
7. Redfield, MM, Jacobsen, SJ, Burnett, JC, Mahoney, DW, Bailey, KR, Rodeheffer, RJ. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community: Appreciating the Scope of the Heart Failure Epidemic. JAMA. 2003; 289:194-202.
8. Spencer KT, Kirkpatrick JN, Mor-Avi V, Decara JM, Lang RM. Age-dependency of the Tei index of myocardial performance. J Am Soc Echocardiogr. 2004; 17:350-352.
9. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell. 2007; 130:247-58.
10. Walsh DA, Van Patten WM. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J. 1994; 8:1227-1236.
11. McConnachie G, Langeberg LK, Scott JD. AKAP signaling complexes: getting to the heart of the matter. Trends in Molecular Medicine. 2006; 12: 317-323.
12. Kass RS and Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003; 112:810-815.
13. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, Marks AR, Olson EN. Dilated cardiomyopathy and sudden death resulting from constitutive activation of Protein Kinase A. Circ Res. 2010; 89:997-1004.
14. Zakhary DR, Moravec CS, Stewart RW, Bond M. 1999. Protein Kinase A (PKA)-dependent Troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation. 1999; 99:505-605.
15. McKnight GS, Cummings DE, Amieux PS, Sikorski MA, Brandon EP et al. Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog Hormone Res. 1998; 53: 139-161.
16. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987; 75:IV80-IV92.
17. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosenblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000; 101:365-376.
18. Enns LC, Morton JF, Mangalindan RS, McKnight GS, Schwartz MW, Kaeberlein MR, Kennedy BK, Rabinovitch PS, Ladiges WC. Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cβ subunit of protein kinase A. J Gerontol. 2009; 64: 1221-1231.
19. Djouder N, Tuerk RD, Suter M, Salvioni P, Thali RF, Scholz R, Vaahtomeri K, Auchli Y, Rechsteiner H, Brunisholz RA, Viollet B, Makela TP, Wallimann T, Neumann D, Krek W. PKA phosphorylates and inactivates AMPK alpha to promote efficient lipolysis. EMBO J. 2010; 29:469-481.
20. Chan AYM, Dyck JRB. Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy. Can J Physiol Pharmacol. 2005; 83:24-28.
21. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, Foretz M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol. 2009; 196:81-98.
22. Howe DG, Wiley JC, McKnight GS. Molecular and behavioural effects of a null mutation in all PKA Cβ isoforms. Mol Cell Neurosci. 2002; 20:515-524.
23. Gamm DM, Baude EJ, Uhler MD. The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. J Biol Chem. 1996; 271:15736-15742.
24. Czyzyk TA, Sikorski MA, Yang L, McKnight GS. Disruption of the RIIβ subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice. Proc Natl Acad Sci USA. 2008; 105:276-281.
25. Ma XH, Muzumdar R, Yang XM, Gabriely I, Berger R, Barzilai N. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J Gerontol A Biol Sci Med Sci. 2002; 57:B225-B231.
26. Minokoshi Y, Kim Y-B, Peroni OD, Fryer LGD, Müller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002; 415:339-343.
27. Ladiges W, Van Remmen H, Strong R, Ikeno Y, Treuting P, Rabinovitch P, Richardson A. Lifespan extension in genetically modified mice. Aging Cell. 2009; 8(4):346-52.